Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

SNES US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

SenesTech, Inc.(SNES US)

$1.08+0.076.93%Ext:$1.10+0.021.53%(Market Closed · 00:00:02 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

SenesTech, Inc. — Company Profile

SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice. The company was incorporated in 2004 and is headquartered in Surprise, Arizona.

Sector
Basic Materials
Industry
Chemicals
Exchange
UQ
CEO
Michael Edell
Headquarters
Surprise, AZ, US
IPO Date
Dec 7, 2016
Employees
24
Website
www.senestech.com

Key Metrics

Price
$0.78
Market Cap
$4.13M
Revenue (TTM)
$493.00K
Net Income (TTM)
$-2063000.00
EPS (TTM)
-0.39
P/E (TTM)
-0.61
P/B (TTM)
0.54
Dividend Yield
0.00%
ROE (TTM)
-26.79%
ROA (TTM)
-18.65%
Operating Margin
-4.30%
Beta
1.08

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice. The company was incorporated in 2004 and is headquartered in Surprise, Arizona.

Website
www.senestech.com
Location
Surprise, AZ, US
Phone928 779 4143
Employees24
CEOMichael Edell
SectorBasic Materials
Industry
Chemicals
IPO DateDec 7, 2016

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Latest Documents

SEC Filings(631)

Expand
  • SC 13GSenesTech, Inc.30 Oct
  • 4GLENBROOK CAPITAL MANAGEMENT30 Oct
  • SC 13D/ASenesTech, Inc.30 Oct
  • SC 13DSenesTech, Inc.26 Oct
  • 4GLENBROOK CAPITAL MANAGEMENT22 Oct
  • SC 13D/ASenesTech, Inc.22 Oct
  • 8-KNotice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing22 Oct
  • 4GLENBROOK CAPITAL MANAGEMENT19 Oct
  • SC 13D/ASenesTech, Inc.19 Oct
  • 8-KResults of Operations and Financial Condition15 Oct
  • 4Statement of changes in beneficial ownership29 Sep
  • 4Statement of changes in beneficial ownership15 Sep
  • 4Statement of changes in beneficial ownership10 Sep
  • S-8Registration statement (employee benefit plan)20 Aug
  • 4Statement of changes in beneficial ownership17 Aug
  • 4GLENBROOK CAPITAL MANAGEMENT10 Aug
  • 10-QQ2ended 30 Jun 20265 Aug
  • 8-KResults of Operations and Financial Condition5 Aug
  • 8-KResults of Operations and Financial Condition3 Aug
  • SC 13DSenesTech, Inc.23 Jul

News

  • SenesTech: Sandstrom Partners Hired As Strategic Advisor on Marketing and Branding28 Oct
  • Sandstrom Partners Hired As Strategic Advisor on Marketing and Branding28 Oct
  • SenesTech Receives Nasdaq Minimum Bid Price Notification and Highlights Record Third Quarter Revenue22 Oct
  • Senestech (NASDAQ:SNES) Major Shareholder Glenbrook Capital Management Purchases 426,000 Shares of Stock20 Oct
  • Senestech (NASDAQ:SNES) Major Shareholder Glenbrook Capital Management Buys 376,552 Shares of Stock20 Oct
  • Senestech (NASDAQ:SNES) Major Shareholder Glenbrook Capital Management Buys 181,252 Shares of Stock20 Oct
  • GLENBROOK CROSSES 30% OWNERSHIP OF SENESTECH19 Oct
  • GLENBROOK CROSSES 30% OWNERSHIP OF SENESTECH19 Oct
  • SenesTech Reports 88% Reduction in Rat Activity in Chicago Pilot, Building on Record $1.1 Million Quarterly Revenue Milestone19 Oct
  • Financial Analysis: Senestech (NASDAQ:SNES) & Axalta Coating Systems (NYSE:AXTA)19 Oct
  • SenesTech Reports Record Preliminary Third Quarter Revenue Exceeding $1 Million, the Highest in Company History, with 40% Sequential Growth15 Oct
  • SenesTech Expands Third-Party E-commerce Distribution with Grove Collaborative, Bringing Evolve® Rodent Birth Control™ Products to Sustainability-Focused Consumers23 Sep
  • Senestech (NASDAQ:SNES) Shares Cross Below 50 Day Moving Average – Should You Sell?18 Sep
  • SenesTech to Participate in the Lytham Partners Fall 2026 Investor Conference17 Sep
  • Swampscott Municipal Integrated Pest Management Program Achieves 43% Reduction in Rodent Activity with Evolve® Rat31 Aug
  • SenesTech Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)27 Aug
  • SenesTech to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 202617 Aug
  • Financial Survey: Senestech (NASDAQ:SNES) & Chemtrade Logistics Income Fund (OTCMKTS:CGIFF)8 Aug
  • SenesTech, Inc. (SNES) Q2 2026 Earnings Call Transcript6 Aug
  • Senestech Q2 Earnings Call Highlights6 Aug

Mentions in Filings

  • … ess of the Company and (ii) do not adversely interfere with his obligations to the Company in any material respect. It is understood that Executive shall be permitted to continue serving on the boards of directors of <strong>SenesTech, Inc.</strong> (Nasdaq: SNES) and INVO Fertility, Inc. (Nasdaq: IVF) (or any successor entities thereto), so long as such service (i) is not competitive with, and does not present a conflict of interest with, the business of the Com …
    Stark Focus Group, Inc.SenesTech, Inc.·EX-10.1 - 8-K - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers·Q3 26·25 Sep
  • Mr. Szot, 52, is the Chairman of the Board of Directors of <strong>SenesTech, Inc.</strong> (Nasdaq: SNES), a position he has held since May 2026. He has served as a director of SenesTech since December 2015. He is also the Chief Financial Officer of Cadrenal Therapeutics, Inc., a late-stage biopharmaceutical company where he has served since May 2022. From March 2010 to November 2021, Mr. Szot served as the Chief Financial Officer of S&W Seed Company, an agricul …
    Stark Focus Group, Inc.SenesTech, Inc.·8-K - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers·Q3 26·25 Sep
  • … ommittee of INVO Fertility, Inc., a Nasdaq-listed commercial- stage fertility company. He also serves on the Board of Directors and as Chairman of the Audit, Compensation, and Nominating and Governance Committees of <strong>SenesTech, Inc.</strong>, a Nasdaq-listed life science company with next-generation technologies for managing animal pest populations through fertility control. From June 2018 to August 2019, Mr. Szot served on the Board of Directors and as …
    Cadrenal Therapeutics, Inc.SenesTech, Inc.·ARS - Annual report to security holders·FY25·3 Aug
  • **Matthew Szot**. Mr. Szot, 52, has been a member of our Board since September 13, 2020, and has served as Chairman of the Audit Committee since September 14, 2020. Mr. Szot currently serves as Chair of the Board of <strong>SenesTech, Inc.</strong> (Nasdaq: SNES), a life sciences company focused on fertility control solutions for animal pest management. He also serves as Chairman of the Audit Committee, a member of the Compensation Committee, and a member of the …
    INVO Fertility, Inc.SenesTech, Inc.·DEF 14A - Definitive proxy statement·Q2 26·23 Jun
  • **Matthew Szot.** Mr. Szot, 52, has been a member of our Board since September 13, 2020, and has served as Chairman of the Audit Committee since September 14, 2020. Mr. Szot currently serves as Chair of the Board of <strong>SenesTech, Inc.</strong> (Nasdaq: SNES), a life sciences company focused on fertility control solutions for animal pest management. He also serves as Chairman of the Audit Committee, a member of the Compensation Committee, and a member of the …
    INVO Fertility, Inc.SenesTech, Inc.·PRE 14A - Preliminary proxy statement·Q2 26·12 Jun
  • **Matthew Szot**. Mr. Szot, 52, has been a member of our Board since September 13, 2020, and has served as Chairman of the Audit Committee since September 14, 2020. Mr. Szot currently serves as Chair of the Board of <strong>SenesTech, Inc.</strong> (Nasdaq: SNES), a life sciences company focused on fertility control solutions for animal pest management. He also serves as Chairman of the Audit Committee, a member of the Compensation Committee, and a member of the …
    INVO Fertility, Inc.SenesTech, Inc.·10-K/A - Annual report (amendment) FY 2025·FY25·12 Jun

Key Stats

Trading

Px/Chg 1D$0.78 / +16.27%
Avg Volume65.15K
Beta1.08
Mkt Cap4.13M
FD Mkt Cap5.57M

Float

Shrs Out/Float5.30M / 4.01M
Short Float0.01%
Days to Cover1.17
Stock Repurchased$0.00

Current Valuation

EV-43631.15
EV/EBITDA0.01
EV/Sales-0.02
P/B0.54
P/S1.85
FCF Yield-46.69%
ROE-26.79%
ROA-18.65%
Current Ratio8.91

Estimates

P/E-0.61
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgMay '23May '24May '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-1.45-0.09-0.07-0.29-4.81-2.00
Price / Sales6.250.850.470.9620.598.38
Price / Book Value0.480.160.090.710.910.54
Price / Free Cash Flow-1.55-0.10-0.07-0.29-5.17-2.14
ENTERPRISE VALUE METRICS
Enterprise Value-0.7-3.6-4.40.73.8-0.0
Enterprise Value / Sales0.41-3.49-3.710.408.96-0.09
Enterprise Value / EBITDA-0.260.370.58-0.12-2.130.02
Enterprise Value / EBIT-0.250.370.57-0.12-2.100.02

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue40.1%0.61.01.21.92.2
Gross Income58.5%0.20.50.51.01.4
EBITDA-5.9%-8.0-9.5-7.6-6.0-6.2
EBIT-6.3%-8.3-9.7-7.7-6.2-6.4
Net Income-6.3%-8.3-9.7-7.7-6.2-6.4
EPS (Diluted)-81.8%-1,773.00-1,860.00-115.10-8.86-1.95
BALANCE SHEET
Cash & ST Inv-2.1%9.34.85.41.38.6
Total Assets2.8%11.56.87.33.312.8
Total Liabilities22.3%1.51.50.90.83.3
Total Shareholder Equity-1.2%10.05.36.42.59.6
CASH FLOW
Net Operating Cash Flow-7.3%-7.8-8.6-7.6-6.0-5.8
Cap Ex8.4%-0.1-0.2-0.1-0.1-0.1
Free Cash Flow-7%-7.9-8.8-7.7-6.1-5.9

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)0.84
Basic Shares5.30
Market Cap4.5
Diluted Shares5.26
Fully Diluted Shares Outstanding5.26
Fully Diluted Market Cap4.4
+Consolidated Debt2.6
−In-the-Money Convertible Debt—
+Capital Leases0.1
+Operating Leases—
−Cash & Equivalents-6.8
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value0.3

Segment data

Revenue

by Products and services

  • Product Sales100%

Related companies

Nutrien Ltd.

NTR US

Qinghai Salt Lake Industry Co.,Ltd

000792 CS

CF Industries Holdings, Inc.

CF US

SABIC Agri-Nutrients Company

SAFCO AB

Yunnan Yuntianhua Co., Ltd.

600096 CG

PJSC Acron

AKRN RX

Mosaic Co

MOS US

UPL Limited

UPLL IB

PI Industries Limited

PI IB

K+s Ag

KPLUY US

Jiangsu Yangnong Chemical Co., Ltd.

600486 CG

Scotts Miracle-gro Co

SMG US